• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据波塞冬标准的良好和低预后患者的累积活产率:18455个治疗周期的单中心分析

Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles.

作者信息

Shi Wenhao, Zhou Hanying, Tian Li, Zhao Zhenghao, Zhang Wei, Shi Juanzi

机构信息

The Assisted Reproduction Center, Northwest Women's and Children's Hospital, Xi'an, China.

Department of Respiratory Medicine, Shaanxi Provincial People's Hospital, Xi'an, China.

出版信息

Front Endocrinol (Lausanne). 2019 Jun 26;10:409. doi: 10.3389/fendo.2019.00409. eCollection 2019.

DOI:10.3389/fendo.2019.00409
PMID:31293519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6606694/
Abstract

To investigate the characteristics and outcomes of low prognosis patients defined by POSEIDON criteria undergoing IVF treatment. Retrospective cohort analysis. An IVF clinic in a public hospital. 18,455 fresh aspirated IVF cycles with subsequently frozen embryo transfer from Jan 2014 to Jan 2017 in a single IVF clinic were included in the analysis. The low prognosis patients were categorized into 4 groups based on POSEIDON criteria: group 1: age < 35, antral follicle count (AFC) ≥ 5, number of oocytes retrieved ≤ 9 in the previous cycle; group 2: age ≥ 35, AFC≥5, number of oocytes retrieved ≤ 9 in the previous cycle; group 3: age < 35, AFC < 5; group 4: age ≥ 35, AFC < 5. The non-low prognosis patients: group 5: AFC ≥ 5, previous number of oocytes retrieved > 9 oocytes; group 6: AFC ≥ 5, no previous ovarian stimulation. None. The primary outcome was cumulative live birth rate (CLBR). Taking group 1 as reference, the CLBR from young women in group 3 (35.5%, OR 0.9, 95% CI 0.7-1.2) was slightly lower than that in group 1 (44.6%, = 0.615). The CLBR in group 2 (24.5%, OR 0.6, 95% CI 0.4-0.8, = 0.004) and group 4 (12.7%, OR 0.4, 95% CI 0.3-0.6, < 0.001) was significant lower than that in group 1. In non-poor prognosis patients, the CLBR from young women in group 5 (53.5% OR 1.3 95% CI 0.9, 1.7, = 0.111) was a slight higher than the reference group 1 while the highest CLBR was originated from the first IVF patients with good ovarian reserve in group 6 (66.9%, OR 2.0, 95% CI 1.6, 2.4). The CLBRs and implantation rates in the young women (group 3) with diminished ovarian reserve was similar in those young women (group 1), and was significantly higher than in advanced age women with a fair ovarian reserve (group 2). Though patients in group 2 had better ovarian reserve, more oocytes and more embryos, the pregnancy outcome was inferior to that of group 3 patients with poorer ovarian reserve, fewer oocytes and fewer embryos.

摘要

为研究符合POSEIDON标准的低预后患者接受体外受精(IVF)治疗的特征及结局。进行回顾性队列分析。研究地点为一家公立医院的IVF诊所。分析纳入了2014年1月至2017年1月在该单一IVF诊所进行的18455个新鲜取卵IVF周期及随后的冻融胚胎移植周期。根据POSEIDON标准,将低预后患者分为4组:第1组:年龄<35岁,窦卵泡计数(AFC)≥5,前一周期获卵数≤9个;第2组:年龄≥35岁,AFC≥5,前一周期获卵数≤9个;第3组:年龄<35岁,AFC<5;第4组:年龄≥35岁,AFC<5。非低预后患者:第5组:AFC≥5,既往获卵数>9个;第6组:AFC≥5,既往未接受过卵巢刺激。无。主要结局为累积活产率(CLBR)。以第1组为参照,第3组年轻女性的CLBR(35.5%,比值比[OR]0.9,95%可信区间[CI]0.7 - 1.2)略低于第1组(44.6%,P = 0.615)。第2组(24.5%,OR 0.6,95%CI 0.4 - 0.8,P = 0.004)和第4组(12.7%,OR 0.4,95%CI 0.3 - 0.6,P<0.001)的CLBR显著低于第1组。在非低预后患者中,第5组年轻女性的CLBR(53.5%,OR 1.3,95%CI 0.9,1.7,P = 0.111)略高于参照组第1组,而CLBR最高的是第6组首次接受IVF且卵巢储备良好的患者(66.9%,OR 2.0,95%CI 1.6,2.4)。卵巢储备功能减退的年轻女性(第3组)的CLBR和种植率与年轻女性(第1组)相似,且显著高于卵巢储备一般的高龄女性(第2组)。尽管第2组患者的卵巢储备更好,获卵数更多,胚胎更多,但其妊娠结局却不如卵巢储备较差、获卵数较少、胚胎较少的第3组患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/1607f3181846/fendo-10-00409-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/00a24bb0bde9/fendo-10-00409-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/2dacf58681ae/fendo-10-00409-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/1607f3181846/fendo-10-00409-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/00a24bb0bde9/fendo-10-00409-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/2dacf58681ae/fendo-10-00409-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6032/6606694/1607f3181846/fendo-10-00409-g0003.jpg

相似文献

1
Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles.根据波塞冬标准的良好和低预后患者的累积活产率:18455个治疗周期的单中心分析
Front Endocrinol (Lausanne). 2019 Jun 26;10:409. doi: 10.3389/fendo.2019.00409. eCollection 2019.
2
Cumulative live birth rates in low-prognosis women.低预后女性的累积活产率。
Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051.
3
Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.1050名女性在一个辅助生殖技术周期(包括所有后续冻融周期)后的累积活产率:一项比较促性腺激素释放激素拮抗剂和促性腺激素释放激素激动剂方案的随机对照试验的次要结果。
Hum Reprod. 2017 Mar 1;32(3):556-567. doi: 10.1093/humrep/dew358.
4
Live birth rate per fresh embryo transfer and cumulative live birth rate in patients with PCOS under the POSEIDON classification: a retrospective study.多囊卵巢综合征患者根据 POSEIDON 分类的新鲜胚胎移植活产率和累积活产率:一项回顾性研究。
Front Endocrinol (Lausanne). 2024 May 28;15:1348771. doi: 10.3389/fendo.2024.1348771. eCollection 2024.
5
Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.根据 POSEIDON 标准,低预后患者中 GnRH-A 与 PPOS 累积活产率的比较:一项队列研究。
Front Endocrinol (Lausanne). 2021 Jun 21;12:644456. doi: 10.3389/fendo.2021.644456. eCollection 2021.
6
The cumulative live birth rates of 18 593 women with progestin-primed ovarian stimulation-related protocols and frozen-thawed transfer cycles.18593名接受孕激素预处理卵巢刺激相关方案及冻融胚胎移植周期的女性的累积活产率。
Hum Reprod Open. 2023 Dec 21;2024(1):hoad051. doi: 10.1093/hropen/hoad051. eCollection 2024.
7
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?体外受精/卵胞浆内单精子注射的传统卵巢刺激和单胚胎移植。在利用所有新鲜和冷冻胚胎后,我们需要多少个卵母细胞才能使累积活产率最大化?
Hum Reprod. 2016 Feb;31(2):370-6. doi: 10.1093/humrep/dev316. Epub 2016 Jan 2.
8
Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles.体外受精-卵胞浆内单精子注射(IVF-ICSI)周期中低预后女性根据包含个体化卵母细胞数量的以患者为导向策略(POSEIDON)分层的累积活产率(CLBR)比较。
J Reprod Infertil. 2023 Apr-Jun;24(2):117-131. doi: 10.18502/jri.v24i2.12497.
9
Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis.POSEIDON 分层低预后患者的累积活产率:单中心数据分析。
Reprod Biomed Online. 2020 Nov;41(5):834-844. doi: 10.1016/j.rbmo.2020.08.003. Epub 2020 Aug 10.
10
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.

引用本文的文献

1
Effect of ovarian reserve on pregnancy outcomes in patients undergoing IVF treatment due to azoospermia.卵巢储备功能对因无精子症接受体外受精治疗患者妊娠结局的影响。
Int Urol Nephrol. 2025 Feb 21. doi: 10.1007/s11255-025-04412-6.
2
The effects of growth hormone on the outcomes of fertilization and embryo transfer in age-grouped patients with decreased ovarian reserve: a prospective cohort study.生长激素对卵巢储备功能下降的不同年龄组患者受精及胚胎移植结局的影响:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2025 Jan 14;15:1457866. doi: 10.3389/fendo.2024.1457866. eCollection 2024.
3
The Effect of Traditional Chinese Medicine Treatment on the Cumulative Live Birth Rate of Patients with Poor Ovarian Response to the Patient-Oriented Strategies Encompassing Individualized Oocyte Number Criteria.

本文引用的文献

1
Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria.了解卵泡输出率(FORT)及其对波塞冬标准的影响。
Front Endocrinol (Lausanne). 2019 Apr 16;10:246. doi: 10.3389/fendo.2019.00246. eCollection 2019.
2
Cumulative live birth rate prognosis based on the number of aspirated oocytes in previous ART cycles.基于前次辅助生殖技术(ART)周期中抽吸的卵母细胞数量预测累积活产率。
Hum Reprod. 2019 Jan 1;34(1):171-180. doi: 10.1093/humrep/dey341.
3
Egg Quality and Pregnancy Outcome in Young Infertile Women with Diminished Ovarian Reserve.
中药治疗对卵巢反应不良患者累积活产率的影响:以个体化卵母细胞数量标准为导向的患者策略
Int J Womens Health. 2024 Dec 28;16:2377-2386. doi: 10.2147/IJWH.S492333. eCollection 2024.
4
Identify high-risk DOR women ≤ 35 years old following assisted reproduction technology through cutoffs of anti-mullerian hormone and antral follicle counts.通过抗缪勒管激素和窦卵泡计数的截断值,识别接受辅助生殖技术的 ≤ 35 岁的高风险 DOR 女性。
Reprod Biol Endocrinol. 2024 Oct 25;22(1):130. doi: 10.1186/s12958-024-01298-4.
5
The role of age and AMH on cumulative live birth rates over multiple frozen-thawed embryo transfer cycles: a study based on low prognosis patients of POSEIDON 3 and 4 groups.年龄和 AMH 对多个冻融胚胎移植周期累积活产率的作用:基于 POSEIDON 3 和 4 组低预后患者的研究。
Reprod Biol Endocrinol. 2024 Jun 17;22(1):69. doi: 10.1186/s12958-024-01243-5.
6
Live birth rate per fresh embryo transfer and cumulative live birth rate in patients with PCOS under the POSEIDON classification: a retrospective study.多囊卵巢综合征患者根据 POSEIDON 分类的新鲜胚胎移植活产率和累积活产率:一项回顾性研究。
Front Endocrinol (Lausanne). 2024 May 28;15:1348771. doi: 10.3389/fendo.2024.1348771. eCollection 2024.
7
Maternal and neonatal complications after IVF/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study.POSEIDON 标准下低预后女性行体外受精/卵胞浆内单精子注射-新鲜胚胎移植后的母婴并发症:一项回顾性队列研究。
BMC Pregnancy Childbirth. 2023 Dec 12;23(1):855. doi: 10.1186/s12884-023-06176-2.
8
Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles.体外受精-卵胞浆内单精子注射(IVF-ICSI)周期中低预后女性根据包含个体化卵母细胞数量的以患者为导向策略(POSEIDON)分层的累积活产率(CLBR)比较。
J Reprod Infertil. 2023 Apr-Jun;24(2):117-131. doi: 10.18502/jri.v24i2.12497.
9
Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study.年轻 POSEIDON 患者接受 IVF/ICSI 治疗周期后的累积活产率和出生结局:一项真实世界研究。
Front Endocrinol (Lausanne). 2023 Mar 30;14:1107406. doi: 10.3389/fendo.2023.1107406. eCollection 2023.
10
Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria.根据 POSEIDON 标准比较卵巢反应不良患者的 ART 结局。
Sci Rep. 2022 Oct 21;12(1):17723. doi: 10.1038/s41598-022-22859-w.
年轻卵巢储备功能减退不孕妇女的卵子质量与妊娠结局。
Med Sci Monit. 2018 Oct 12;24:7279-7284. doi: 10.12659/MSM.910410.
4
Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old.高龄妇女的累积活产率和取卵数。包括 4500 名≥38 岁妇女的单个中心分析。
Hum Reprod. 2018 Nov 1;33(11):2010-2017. doi: 10.1093/humrep/dey295.
5
Status of preimplantation genetic testing and embryo selection.胚胎植入前遗传学检测与胚胎选择的现状。
Reprod Biomed Online. 2018 Oct;37(4):393-396. doi: 10.1016/j.rbmo.2018.08.001. Epub 2018 Aug 20.
6
Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women.根据体外受精/胞浆内单精子注射第一次卵巢刺激后获得的卵母细胞数量计算的累积活产率:一项包括约 15000 名妇女的多中心、多国分析。
Fertil Steril. 2018 Sep;110(4):661-670.e1. doi: 10.1016/j.fertnstert.2018.04.039.
7
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.界定接受辅助生殖技术的低预后患者:POSEIDON标准——原因
Front Endocrinol (Lausanne). 2018 Aug 17;9:461. doi: 10.3389/fendo.2018.00461. eCollection 2018.
8
Luteal Phase Ovarian Stimulation May Improve Oocyte Retrieval and Oocyte Quality in Poor Ovarian Responders Undergoing In Vitro Fertilization: Preliminary Results from a Single-Center Prospective Pilot Study.黄体期卵巢刺激可能改善体外受精中卵巢反应不良者的卵母细胞获取和卵母细胞质量:来自单中心前瞻性初步研究的结果。
Adv Ther. 2018 Jun;35(6):847-856. doi: 10.1007/s12325-018-0713-1. Epub 2018 Jun 4.
9
Individualized controlled ovarian stimulation in expected poor-responders: an update.个体化控制性卵巢刺激在预期卵巢低反应患者中的应用:更新。
Reprod Biol Endocrinol. 2018 Mar 9;16(1):20. doi: 10.1186/s12958-018-0342-1.
10
Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies.卵母细胞衰老构成女性生殖衰老的基础:生物学机制与治疗策略。
Reprod Med Biol. 2015 May 9;14(4):159-169. doi: 10.1007/s12522-015-0209-5. eCollection 2015 Oct.